Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Long-acting injectable (LAI) is a kind of pharmaceutical for treating patients with schizophrenia who relapse due to nonadherence to antipsychotic medication. Rather than the daily pill-taking required with oral antipsychotics, LAI antipsychotics are administered by injection at two to four weeks intervals.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Long-Acting Injectables market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Long-Acting Injectables market. Detailed analysis of key players, along with key growth strategies adopted by Long-Acting Injectables industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Otsuka
Johnson and Johnson
Alkermes
Sanofi
Pfizer
GlaxoSmithKline
Eli Lilly
By Type:
Small and Middle Sized Molecule
Large Sized Molecule
By End-User:
Schizophrenia
Other Psychotic Disorders
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Long-Acting Injectables Market
-
1.3 Market Segment by Type
-
1.3.1 China Long-Acting Injectables Market Size and Growth Rate of Small and Middle Sized Molecule from 2016 to 2027
-
1.3.2 China Long-Acting Injectables Market Size and Growth Rate of Large Sized Molecule from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Long-Acting Injectables Market Size and Growth Rate of Schizophrenia from 2016 to 2027
-
1.4.2 China Long-Acting Injectables Market Size and Growth Rate of Other Psychotic Disorders from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Long-Acting Injectables Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Long-Acting Injectables Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Long-Acting Injectables Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Long-Acting Injectables Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Long-Acting Injectables Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Long-Acting Injectables Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Long-Acting Injectables Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Long-Acting Injectables Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Long-Acting Injectables by Major Types
-
3.4.1 Market Size and Growth Rate of Small and Middle Sized Molecule
-
3.4.2 Market Size and Growth Rate of Large Sized Molecule
4 Segmentation of Long-Acting Injectables Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Long-Acting Injectables by Major End-Users
-
4.4.1 Market Size and Growth Rate of Long-Acting Injectables in Schizophrenia
-
4.4.2 Market Size and Growth Rate of Long-Acting Injectables in Other Psychotic Disorders
5 Market Analysis by Regions
-
5.1 China Long-Acting Injectables Production Analysis by Regions
-
5.2 China Long-Acting Injectables Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Long-Acting Injectables Landscape Analysis
-
6.1 North China Long-Acting Injectables Landscape Analysis by Major Types
-
6.2 North China Long-Acting Injectables Landscape Analysis by Major End-Users
7 Central China Long-Acting Injectables Landscape Analysis
-
7.1 Central China Long-Acting Injectables Landscape Analysis by Major Types
-
7.2 Central China Long-Acting Injectables Landscape Analysis by Major End-Users
8 South China Long-Acting Injectables Landscape Analysis
-
8.1 South China Long-Acting Injectables Landscape Analysis by Major Types
-
8.2 South China Long-Acting Injectables Landscape Analysis by Major End-Users
9 East China Long-Acting Injectables Landscape Analysis
-
9.1 East China Long-Acting Injectables Landscape Analysis by Major Types
-
9.2 East China Long-Acting Injectables Landscape Analysis by Major End-Users
10 Northeast China Long-Acting Injectables Landscape Analysis
-
10.1 Northeast China Long-Acting Injectables Landscape Analysis by Major Types
-
10.2 Northeast China Long-Acting Injectables Landscape Analysis by Major End-Users
11 Southwest China Long-Acting Injectables Landscape Analysis
-
11.1 Southwest China Long-Acting Injectables Landscape Analysis by Major Types
-
11.2 Southwest China Long-Acting Injectables Landscape Analysis by Major End-Users
12 Northwest China Long-Acting Injectables Landscape Analysis
-
12.1 Northwest China Long-Acting Injectables Landscape Analysis by Major Types
-
12.2 Northwest China Long-Acting Injectables Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Otsuka
-
13.1.1 Otsuka Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Johnson and Johnson
-
13.2.1 Johnson and Johnson Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Alkermes
-
13.3.1 Alkermes Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Sanofi
-
13.4.1 Sanofi Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Pfizer
-
13.5.1 Pfizer Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 GlaxoSmithKline
-
13.6.1 GlaxoSmithKline Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Eli Lilly
-
13.7.1 Eli Lilly Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Long-Acting Injectables Market Size and Growth Rate of Small and Middle Sized Molecule from 2016 to 2027
-
Figure China Long-Acting Injectables Market Size and Growth Rate of Large Sized Molecule from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Long-Acting Injectables Market Size and Growth Rate of Schizophrenia from 2016 to 2027
-
Figure China Long-Acting Injectables Market Size and Growth Rate of Other Psychotic Disorders from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Long-Acting Injectables Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Long-Acting Injectables Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Long-Acting Injectables Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Long-Acting Injectables Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Long-Acting Injectables Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Long-Acting Injectables Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Long-Acting Injectables Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Long-Acting Injectables Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Long-Acting Injectables
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Long-Acting Injectables by Different Types from 2016 to 2027
-
Table Consumption Share of Long-Acting Injectables by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Small and Middle Sized Molecule
-
Figure Market Size and Growth Rate of Large Sized Molecule
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Long-Acting Injectables by Different End-Users from 2016 to 2027
-
Table Consumption Share of Long-Acting Injectables by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Schizophrenia
-
Figure Market Size and Growth Rate of Other Psychotic Disorders
-
Table China Long-Acting Injectables Production by Regions
-
Table China Long-Acting Injectables Production Share by Regions
-
Figure China Long-Acting Injectables Production Share by Regions in 2016
-
Figure China Long-Acting Injectables Production Share by Regions in 2021
-
Figure China Long-Acting Injectables Production Share by Regions in 2027
-
Table China Long-Acting Injectables Consumption by Regions
-
Table China Long-Acting Injectables Consumption Share by Regions
-
Figure China Long-Acting Injectables Consumption Share by Regions in 2016
-
Figure China Long-Acting Injectables Consumption Share by Regions in 2021
-
Figure China Long-Acting Injectables Consumption Share by Regions in 2027
-
Table North China Long-Acting Injectables Consumption by Types from 2016 to 2027
-
Table North China Long-Acting Injectables Consumption Share by Types from 2016 to 2027
-
Figure North China Long-Acting Injectables Consumption Share by Types in 2016
-
Figure North China Long-Acting Injectables Consumption Share by Types in 2021
-
Figure North China Long-Acting Injectables Consumption Share by Types in 2027
-
Table North China Long-Acting Injectables Consumption by End-Users from 2016 to 2027
-
Table North China Long-Acting Injectables Consumption Share by End-Users from 2016 to 2027
-
Figure North China Long-Acting Injectables Consumption Share by End-Users in 2016
-
Figure North China Long-Acting Injectables Consumption Share by End-Users in 2021
-
Figure North China Long-Acting Injectables Consumption Share by End-Users in 2027
-
Table Central China Long-Acting Injectables Consumption by Types from 2016 to 2027
-
Table Central China Long-Acting Injectables Consumption Share by Types from 2016 to 2027
-
Figure Central China Long-Acting Injectables Consumption Share by Types in 2016
-
Figure Central China Long-Acting Injectables Consumption Share by Types in 2021
-
Figure Central China Long-Acting Injectables Consumption Share by Types in 2027
-
Table Central China Long-Acting Injectables Consumption by End-Users from 2016 to 2027
-
Table Central China Long-Acting Injectables Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Long-Acting Injectables Consumption Share by End-Users in 2016
-
Figure Central China Long-Acting Injectables Consumption Share by End-Users in 2021
-
Figure Central China Long-Acting Injectables Consumption Share by End-Users in 2027
-
Table South China Long-Acting Injectables Consumption by Types from 2016 to 2027
-
Table South China Long-Acting Injectables Consumption Share by Types from 2016 to 2027
-
Figure South China Long-Acting Injectables Consumption Share by Types in 2016
-
Figure South China Long-Acting Injectables Consumption Share by Types in 2021
-
Figure South China Long-Acting Injectables Consumption Share by Types in 2027
-
Table South China Long-Acting Injectables Consumption by End-Users from 2016 to 2027
-
Table South China Long-Acting Injectables Consumption Share by End-Users from 2016 to 2027
-
Figure South China Long-Acting Injectables Consumption Share by End-Users in 2016
-
Figure South China Long-Acting Injectables Consumption Share by End-Users in 2021
-
Figure South China Long-Acting Injectables Consumption Share by End-Users in 2027
-
Table East China Long-Acting Injectables Consumption by Types from 2016 to 2027
-
Table East China Long-Acting Injectables Consumption Share by Types from 2016 to 2027
-
Figure East China Long-Acting Injectables Consumption Share by Types in 2016
-
Figure East China Long-Acting Injectables Consumption Share by Types in 2021
-
Figure East China Long-Acting Injectables Consumption Share by Types in 2027
-
Table East China Long-Acting Injectables Consumption by End-Users from 2016 to 2027
-
Table East China Long-Acting Injectables Consumption Share by End-Users from 2016 to 2027
-
Figure East China Long-Acting Injectables Consumption Share by End-Users in 2016
-
Figure East China Long-Acting Injectables Consumption Share by End-Users in 2021
-
Figure East China Long-Acting Injectables Consumption Share by End-Users in 2027
-
Table Northeast China Long-Acting Injectables Consumption by Types from 2016 to 2027
-
Table Northeast China Long-Acting Injectables Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Long-Acting Injectables Consumption Share by Types in 2016
-
Figure Northeast China Long-Acting Injectables Consumption Share by Types in 2021
-
Figure Northeast China Long-Acting Injectables Consumption Share by Types in 2027
-
Table Northeast China Long-Acting Injectables Consumption by End-Users from 2016 to 2027
-
Table Northeast China Long-Acting Injectables Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Long-Acting Injectables Consumption Share by End-Users in 2016
-
Figure Northeast China Long-Acting Injectables Consumption Share by End-Users in 2021
-
Figure Northeast China Long-Acting Injectables Consumption Share by End-Users in 2027
-
Table Southwest China Long-Acting Injectables Consumption by Types from 2016 to 2027
-
Table Southwest China Long-Acting Injectables Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Long-Acting Injectables Consumption Share by Types in 2016
-
Figure Southwest China Long-Acting Injectables Consumption Share by Types in 2021
-
Figure Southwest China Long-Acting Injectables Consumption Share by Types in 2027
-
Table Southwest China Long-Acting Injectables Consumption by End-Users from 2016 to 2027
-
Table Southwest China Long-Acting Injectables Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Long-Acting Injectables Consumption Share by End-Users in 2016
-
Figure Southwest China Long-Acting Injectables Consumption Share by End-Users in 2021
-
Figure Southwest China Long-Acting Injectables Consumption Share by End-Users in 2027
-
Table Northwest China Long-Acting Injectables Consumption by Types from 2016 to 2027
-
Table Northwest China Long-Acting Injectables Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Long-Acting Injectables Consumption Share by Types in 2016
-
Figure Northwest China Long-Acting Injectables Consumption Share by Types in 2021
-
Figure Northwest China Long-Acting Injectables Consumption Share by Types in 2027
-
Table Northwest China Long-Acting Injectables Consumption by End-Users from 2016 to 2027
-
Table Northwest China Long-Acting Injectables Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Long-Acting Injectables Consumption Share by End-Users in 2016
-
Figure Northwest China Long-Acting Injectables Consumption Share by End-Users in 2021
-
Figure Northwest China Long-Acting Injectables Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Otsuka
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Otsuka
-
Figure Sales and Growth Rate Analysis of Otsuka
-
Figure Revenue and Market Share Analysis of Otsuka
-
Table Product and Service Introduction of Otsuka
-
Table Company Profile and Development Status of Johnson and Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson and Johnson
-
Figure Sales and Growth Rate Analysis of Johnson and Johnson
-
Figure Revenue and Market Share Analysis of Johnson and Johnson
-
Table Product and Service Introduction of Johnson and Johnson
-
Table Company Profile and Development Status of Alkermes
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alkermes
-
Figure Sales and Growth Rate Analysis of Alkermes
-
Figure Revenue and Market Share Analysis of Alkermes
-
Table Product and Service Introduction of Alkermes
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of GlaxoSmithKline
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline
-
Table Product and Service Introduction of GlaxoSmithKline
-
Table Company Profile and Development Status of Eli Lilly
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly
-
Figure Sales and Growth Rate Analysis of Eli Lilly
-
Figure Revenue and Market Share Analysis of Eli Lilly
-
Table Product and Service Introduction of Eli Lilly
-
